Systematic review and meta-analysis of traditional Chinese medicine in the treatment of constipation-predominant irritable bowel syndrome.

ABSTRACT:

Aim

This meta-analysis analyzed the efficacy and safety of traditional Chinese medicine (TCM) for the treatment of irritable bowel syndrome with constipation (IBS-C).

Methods

We searched seven electronic databases for randomized controlled trials investigating the efficacy of TCM in the treatment of IBS-C. The search period was from inception to June 1, 2017. Eligible RCTs compared TCM with cisapride and mosapride. Article quality was evaluated with the Cochrane Risk Bias Tool in the Cochrane Handbook by two independent reviewers. Begg's test was performed to evaluate publication bias. Review Manager 5.3 and Stata 12.0 were used for analyses.

Results

Eleven eligible studies comprising a total of 906 participants were identified. In the primary outcome, TCM showed sign

SUBMITTER: Li DY 

PROVIDER: S-EPMC5734785 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature